Leiomyosarcoma of the kidney: report of a patient with favorable response to doxorubicin and cisplatin suspended in a lipid contrast medium and cyclophosphamide.
A man who had unresectable leiomyosarcoma of the left kidney with skin and lung metastases was treated with intra-arterial infusion chemotherapy consisting of cisplatin and doxorubicin suspended in lipid contrast medium, lipiodol, and oral administration of cyclophosphamide. The tumor responded well to this treatment three times. He is alive and well in remission, the renal tumor decreased in size, and lung metastases became unclear more than 50 weeks after treatment was completed.
Taniguchi
H
H
First Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Takahashi
T
T
Fujita
Y
Y
Sakita
M
M
Ogita
S
S
Sawai
K
K
Yamaguchi
T
T
Yokota
T
T
Nakagawa
N
N
Shimotsuma
M
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003287:Contrast Media / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D007890:Leiomyosarcoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D011859:Radiography; D012878:Skin Neoplasms / Q000556:secondary
D003287:Contrast Media; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin